The Clinical Value of Immuno-Oncological Treatments in Early Breast Cancer
At the Onkologiapäivät conference in Finland, Professor Peeter Karihtala , University of Helsinki and Research Director at Helsinki University Hospital, presented an overview of the current landscape of immuno-oncological therapies in early breast cancer.
In this MEDtalk, Professor Peeter Karihtala shares his key insights and perspectives from the presentation.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
